These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 21658659)

  • 1. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
    Singh ZN; Post GR; Kiwan E; Maddox AM
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E; Steensma DP
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
    Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
    Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Castoldi G
    Haematologica; 1997; 82(1):25-30. PubMed ID: 9107078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems.
    Breccia M; Cannella L; Frustaci A; Stefanizzi C; D'Elia GM; Alimena G
    Leuk Lymphoma; 2008 Jul; 49(7):1292-6. PubMed ID: 18604717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and hematological aspects of chronic myelomonocytic leukemia. Study on 20 cases from a single center from Romania.
    Gologan R; Berceanu A; Colita A; Codreanu V; Dobrea C; Geoada L; Iacob V; Niculescu-Mizil E; Ostroveanu D; Puşcariu T; Ursuleac I
    Rom J Intern Med; 2002; 40(1-4):95-102. PubMed ID: 15526545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.
    Valent P
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101137. PubMed ID: 32460976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
    Baumgartner F; Baer C; Bamopoulos S; Ayoub E; Truger M; Meggendorfer M; Lenk M; Hoermann G; Hutter S; Müller H; Walter W; Müller ML; Nadarajah N; Blombery P; Keller U; Kern W; Haferlach C; Haferlach T
    Blood; 2024 Mar; 143(12):1139-1156. PubMed ID: 38064663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
    Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
    Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
    Calvo X; Garcia-Gisbert N; Parraga I; Gibert J; Florensa L; Andrade-Campos M; Merchan B; Garcia-Avila S; Montesdeoca S; Fernández-Rodríguez C; Salido M; Puiggros A; Espinet B; Colomo L; Roman-Bravo D; Bellosillo B; Ferrer A; Arenillas L
    Blood Adv; 2020 Oct; 4(20):5285-5296. PubMed ID: 33108455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.
    Hu Z; Ramos CEB; Medeiros LJ; Zhao C; Yin CC; Li S; Hu S; Wang W; Thakral B; Xu J; Verstovsek S; Lin P
    Hum Pathol; 2019 Mar; 85():290-298. PubMed ID: 30447300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.